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similar amino acid sequence (over 70% identity), theyYan Geng,* Wendy Whoriskey,* Mary Y. Park,²
display only weak sequence relatedness with cyclin ERoderick T. Bronson,³ Rene H. Medema,§ Tiansen Li,‖
(38% within the most conserved ªcyclin boxº domain)Robert A. Weinberg,² and Piotr Sicinski*#
(Inaba et al., 1992; Xiong et al., 1992). In fact, cyclin E*Dana-Farber Cancer Institute
shares more similarity with the S phase± and M phase±and Department of Pathology
specific cyclins A, B1, and B2 than with the D-typeHarvard Medical School
cyclins (Xiong et al., 1992).Boston, Massachusetts 02115
The expression of these two classes of G1 cyclins²Whitehead Institute for Biomedical Research
occurs at different points of cell cycle progression andand Department of Biology
is governed by distinct mechanisms. Thus, the expres-Massachusetts Institute of Technology
sion of D-type cyclins is controlled largely and perhapsCambridge, Massachusetts 02142
entirely by extracellular signals. Cyclin D1 in particular³Department of Pathology
is rapidly induced following mitogen challenge; its levelsTufts University Schools of Medicine and
rapidly decline when mitogens are withdrawn or whenVeterinary Medicine
antimitogens are added. For this reason, D-cyclins areBoston, Massachusetts 02111
regarded as functional links between the extracellular§Jordan Laboratory
environment and the cell cycle machinery (Sherr, 1993).Department of Hematology
In contrast to the regulation of the D-type cyclins, theUniversity Medical Center
expression of cyclin E is controlled by an autonomousUtrecht 3584 CX
mechanism and peaks suddenly at the G1/S boundary.The Netherlands
Once induced, D-cyclins bind and activate CDK4 and‖Berman-Gund Laboratory for the Study of
CDK6, while cyclin E associates with an entirely differentRetinal Degenerations
catalytic partner, CDK2. Moreover, the cyclin D± andHarvard Medical School
cyclin E±associated CDK complexes are activated atMassachusetts Eye and Ear Infirmary
different times during cell cycle progression, cyclinBoston, Massachusetts 02114
D±CDK4/6 complexes being active during the mid-G1
phase, whereas active cyclin E-CDK2 complexes are
found at the G1/S boundary (Sherr, 1993). The activitySummary
of cyclin D±CDK4/6 complexes is negatively controlled
by association with inhibitory molecules belonging to
D-type cyclins and cyclin E represent two very distinct the INK4 family of CDK inhibitors. In contrast, cyclin
classes of mammalian G1 cyclins. We have generated E±CDK2 complexes appear to be immune to inhibition
a mouse strain in which the coding sequences of the by members of this family of proteins (Sherr and Roberts,
cyclin D1 gene (Ccnd1) have been deleted and re- 1995).
placed by those of human cyclin E (CCNE). In the tis- In the past, we and others generated mice lacking
sues and cells of these mice, the expression pattern cyclin D1 using gene targeting in embryonal stem cells
of human cyclin E faithfully reproduces that normally (Fantl et al., 1995; Sicinski et al., 1995). We found that
associated with mouse cyclin D1. The replacement of these cyclin D12/2 mice display several distinct tissue-
cyclin D1 with cyclin E rescues all phenotypic manifes- specific phenotypes, namely a neurologic abnormality,
tations of cyclin D1 deficiency and restores normal hypoplastic retinas, and the failure to undergo normal
development in cyclin D1±dependent tissues. Thus, mammary epithelial development during pregnancy. In
cyclin E can functionally replace cyclin D1. Our analy- the present study, we have used the properties of these
ses suggest that cyclin E is the major downstream cyclin D1±deficient mice as a tool to gauge the specific
target of cyclin D1. roles of cyclin D1 versus cyclin E in cell proliferation.
To this end, we have created a cyclin E→D1 knockin
Introduction strain of mice in which the coding exons of the cyclin
D1 gene (Ccnd1) have been deleted and replaced by a
Cyclins constitute critical components of the core cell human cyclin E (CCNE) cDNA. Like the cyclin D12/2
cycle machinery in eukaryotic cells. They function to mice, these cyclin E→D1 mice lack cyclin D1 but express
activate and provide substrate specificity to their part- cyclin E in its place. By studying the phenotypes of these
ners, the cyclin-dependent kinases (CDKs). Two classes mice, we have asked whether cyclin E can functionally
of cyclins are expressed in mammalian cells during the substitute for cyclin D1 in various tissues of the mouse
and rescue the phenotypic manifestations of cyclin D1G1 phase of the cell cycle: D-type cyclins (cyclins D1,
deficiency.D2, and D3) and cyclin E (Sherr, 1993). Although these
proteins are collectively referred to as ªG1 cyclins,º
Resultsthere are profound differences between the two G1
cyclin classes. While the three D-type cyclins share very
Generation of Cyclin E→D1 Knockin Mice
In order to replace the coding sequences of cyclin D1# To whom correspondence should be addressed (e-mail: piotr_
sicinski@dfci.harvard.edu). gene with that of cyclin E, we prepared a gene-targeting
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Figure 1. Replacement of the Cyclin D1 Gene
by Cyclin E
(A) Restriction map of the mouse cyclin D1
gene and the structure of cyclin E→D1
knockin vector. The coding exons are de-
picted as boxes and are numbered. Genomic
fragments used as probes for Southern blot-
ting are marked (probes A and B); arrows
denote PCR primers (C, D, and E) used for
genotyping the animals. Cyclin D1 un-trans,
59-untranslated region of cyclin D1; PGK-
Neo, the neomycin transferase gene; PGK-
TK, thymidine kinase gene. Restriction en-
zyme sites: X, XbaI; E, EagI; H, HindIII; R,
EcoRI; K, KpnI; Xh, XhoI; St, StuI; Sa, SalI; Sf,
SfiI.
(B) Western blot analysis of extracts prepared
from indicated tissues or from embryonal fi-
broblasts (MEFs) derived from wild-type
(WT), cyclin E→D1 (KI), or cyclin D12/2 mice
(KO) probed with indicated antibodies.
(C) Western blot analysis of extracts prepared
from indicated tissues derived from wild-type
(WT) or cyclin E→D1 (KI) mice probed with
indicated antibodies.
construct in which the coding exons of the cyclin D1 As is evident from Figure 1C, the two cyclins showed
very distinct, tissue-specific patterns of expression ingene were removed and replaced with a human cyclin
E cDNA (Figure 1A). The use of a human cyclin rather wild-type mice. For instance, cyclin D1 levels were found
to be high in the lung but low in the brain; the conversethan its mouse homolog enables us to distinguish be-
tween the product of the introduced human cyclin E was true for cyclin E. We then prepared protein lysates
from corresponding tissues of homozygous cyclin E→D1gene and the endogenous mouse cyclin E protein, using
an antibody that recognizes human cyclin E but not its mice and probed them with an antibody that specifically
recognizes human cyclin E but not its mouse counter-mouse counterpart. Mouse and human cyclin E display
85% sequence similarity, and for this reason, we pre- part. These analyses revealed that in the tissues of the
knockin mice, human cyclin E is expressed in a tissue-dicted that they would be functionally interchangeable.
The knockin construct was electroporated into em- specific fashion that precisely mirrors that of cyclin D1
in wild-type animals (Figure 1C).bryonal stem (ES) cells, and heterozygous ES cells in
which a homologous recombination event occurred We then asked whether human cyclin E in cells of
cyclin E→D1 mice was expressed in the same parts ofwere identified by Southern blotting. Heterozygous ES
cells were then injected into mouse blastocysts, yielding the cell cycle in which cyclin D1 is normally expressed.
To address this issue, we isolated mouse embryo fibro-chimeric mice. The chimeric mice were bred to produce
cyclin E→D1/1 heterozygotes that were then crossed, blasts (MEFs) derived from cyclin E→D1 or control wild-
type mice and cultured these cells in vitro. The MEFsgiving rise to the cyclin E→D1 homozygous knockin
mice described below. were rendered quiescent by serum deprivation and then
stimulated to enter the cell cycle by serum addition;
the entrance of cells into S phase was determined byPatterns of Cyclin D1 and Cyclin E Expression
in the Knockin Mice measuring tritiated thymidine uptake. These analyses
revealed that both wild-type and cyclin E→D1 cells en-To verify that the homozygous cyclin E→D1 mice indeed
lack cyclin D1, we prepared protein lysates from tissues tered the S phase synchronously and with the same lag
period, beginning at 15 hr following serum stimulationderived from these animals, from control wild-type mice,
and from cyclin D12/2 mice and probed these lysates (not shown).
We then prepared protein lysates from cells harvestedwith anti-cyclin D1 antibodies. These analyses con-
firmed the absence of cyclin D1 protein in the tissues at different time points after serum addition and probed
them with antibodies directed against mouse cyclin D1,of cyclin E→D1 mice (Figure 1B). Reprobing of the same
blots with antibodies directed against human cyclin E the endogenous mouse cyclin E, or the ectopically ex-
pressed human cyclin E. As anticipated, in the wild-typerevealed the presence of human cyclin E in the tissues
of cyclin E→D1 mice but not in those of wild-type or cells, cyclin D1 was induced approximately at 10 hr
following serum challenge (Figure 2A). The induction ofcyclin D12/2 mice (Figure 1B).
The knockin vector used here was designed to place the endogenous mouse cyclin E in these wild-type cells
took place several hours later and coincided with Sthe expression of human cyclin E under control of the
mouse cyclin D1 promoter. Accordingly, we anticipated phase entry (Figure 2A and not shown). In contrast,
cyclin E→D1 MEFs did not express cyclin D1 but insteadthat human cyclin E would be expressed in tissue com-
partments that normally express cyclin D1. To test this expressed human cyclin E, which was induced approxi-
mately 10 hr following serum challengeÐprecisely theprediction, we first determined the normal expression
pattern of cyclins D1 and E in the tissues of wild-type same time cyclin D1 appeared in the wild-type MEFs
(Figure 2A). Thus, when the cyclin E coding sequencesanimals using Western blotting.
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(Fantl et al., 1995; Sicinski et al., 1995), cyclin D12/2 mice
exhibited behavior that strongly suggested a neurologic
abnormality: they display a leg-clasping reflex by re-
tracting their limbs toward their trunks when they are
lifted by their tails. Wild-type mice, in contrast, invariably
respond by extending their legs (Figure 3A).
Two other traits of cyclin D12/2 mice indicated a devel-
opmental abnormality, possibly associated with the ner-
vous system. First, growth of these mice was retarded,
and by 3 weeks of life, cyclin D1±deficient mice were
approximately two times smaller than wild-type lit-
termates (Figure 3B). In addition, a large fraction of
cyclin D12/2 mice died early in life, usually within the
first month (Sicinski et al., 1995).
In striking contrast to cyclin D12/2 mice, the homozy-
gous cyclin E→D1 knockin mice appeared to be com-
pletely normal and were outwardly indistinguishable
from wild-type and heterozygous littermates. They had
normal body size, exhibited no premature mortality, and
never displayed the leg-clasping abnormality (Figures
3A and 3C). Hence, the expression of cyclin E in place
of cyclin D1 fully rescues all of the developmental de-
Figure 2. Cell Cycle±Specific Expression of Knockin Cyclin E fects of cyclin D1±deficient mice. Since the precise his-
(A) Levels of cyclin D1, endogenous mouse cyclin E, and ectopically topathological basis of these defects in the cyclin D12/2
expressed human cyclin E during cell cycle progression of wild-
mice has not been identified, we could not determinetype (WT) or cyclin E→D1 (KI) mouse embryo fibroblasts.
whether this defect was fully cured by the ectopically(B) Kinase activity associated with endogenous mouse cyclin E and
expressed cyclin E.ectopically expressed human cyclin E during cell cycle progression
of cyclin E→D1 mouse embryo fibroblasts. Protein extracts were
subjected to immunoprecipitation (IP) with antibodies against Effects of Knockin Cyclin E on the Retinal
mouse cyclin E or human cyclin E, and kinase activity toward histone
Phenotype of Cyclin D12/2 MiceH1 was determined. Numbers below the lanes indicate hours after
We and others reported previously that cyclin D1±serum stimulation.
deficient mice display a dramatic reduction in cell num-
bers in all layers of the neural retina (Fantl et al., 1995;
Sicinski et al., 1995). Independent of this, we noted veryare placed under the control of the cyclin D1 promoter,
high levels of cyclin D1 in the developing retinas of wild-expression of the cyclin E protein is redirected to a time
type embryos (Sicinski et al., 1995). We thus speculatedin the G1 phase when cyclin D1 is normally expressed.
that the profound effects of cyclin D1 inactivation onWe then asked whether the kinase activity associated
retinal development are related to the intense expres-with human cyclin E parallels the induction of cyclin E
sion of cyclin D1 in this tissue in wild-type mice.protein. To gauge this, protein lysates prepared from
To assess whether human cyclin E could replacecyclin E→D1 MEFs were split in half; one-half was sub-
cyclin D1 in driving retinal proliferation, we first deter-jected to immunoprecipitation with an antibody recog-
mined the expression pattern of human cyclin E mRNAnizing the endogenous mouse cyclin E, while the second
in the developing retinas of cyclin E→D1 mice throughhalf was incubated with an antibody directed against
use of in situ hybridization and compared this patternthe ectopically expressed human cyclin E. The kinase
with that of cyclin D1 in wild-type retinas. As expected,activity in the immunoprecipitates was then determined
retinas derived from wild-type mice expressed very highusing histone H1 as a substrate. In parallel, extracts
levels of cyclin D1 mRNA but no human cyclin E mRNAfrom wild-type cells were analyzed.
(Figure 4). Conversely, the retinas derived from cyclinThese analyses revealed that in both the wild-type
E→D1 embryos lacked cyclin D1, instead expressingand cyclin E→D1 cells, the kinase activity associated
human cyclin E mRNA. Importantly, the expression ofwith the endogenous mouse cyclin E peaked during the
human cyclin E was strictly confined to the neural partS phase, 18±21 hr after serum stimulation (Figure 2B
of the retina, precisely mirroring the expression of cyclinand not shown). In contrast, the kinase activity associ-
D1 in wild-type retinas (Figure 4).ated with human cyclin E in cyclin E→D1 cells peaked
We then determined whether human cyclin E couldabout 6 hr earlier at a time 12±15 hr after serum stimula-
replace cyclin D1 and rescue the phenotypic manifesta-tion (Figure 2B). Thus, the kinase activity associated
tions of cyclin D1 deficiency in retinal development. Towith human cyclin E parallels the induction of human
address this question, we examined the histological ap-cyclin E protein.
pearance of retinas derived from cyclin E→D1 mice and
compared them with cyclin D12/2 and wild-type retinas.
As reported previously, cyclin D1±deficient mice devel-Appearance of the Knockin Mice
Having verified the expression pattern of knockin human oped hypoplastic, disorganized retinal tissue. In striking
contrast, the retinas of cyclin E→D1 had nearly normalcyclin E, we asked whether cyclin E could functionally
replace cyclin D1 and rescue the phenotypic manifesta- appearance (Figure 5A).
In order to obtain a functional measure of the observedtions of cyclin D1 deficiency. As reported previously
Cell
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Figure 3. Phenotype of Cyclin E→D1 Mice as
Compared with Cyclin D12/2 Mice
(A) Rescue of growth retardation and abnor-
mal leg-clasping reflex in cyclin E→D1 mice.
When lifted by their tails, cyclin D12/2 mice
(KO) draw their limbs toward the trunk, while
the cyclin E→D1 (KI) or wild-type (WT) mice
respond by extending their legs.
(B) Representative growth curve of wild-type,
heterozygous, and cyclin D12/2 littermates.
One cyclin D12/2 mutant died at day 21.
(C) Representative growth curve of wild-type,
heterozygous, and homozygous cyclin E→D1
littermates.
rescue, we subjected wild-type, cyclin D12/2, and cyclin flat ERG readout. In contrast, cyclin E→D1 mice re-
sponded to light with nearly normal ERG potentials (Fig-E→D1 mice to electroretinographic (ERG) testing. In this
procedure, mice are exposed to a short pulse of light, ure 5A). The ERG amplitudes in cyclin E→D1 mice were
approximately 70% of the values seen in wild-type mice,and the electrophysiologic potentials generated in their
retinas are recorded (Steinberg et al., 1991). in agreement with the slightly reduced cell numbers
in knockin retinas (Figure 5B). Taken together, theseAs expected, wild-type mice responded to light by
evoking a robust ERG response. Cyclin D12/2 mice failed analyses revealed that while cyclin D1 is critically re-
quired for retinal proliferation, human cyclin E, whento normally respond to light and displayed an essentially
Replacement of Cyclin D1 by Cyclin E
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Figure 4. Expression of Cyclin mRNA in the
Retinas of Wild-Type and Cyclin E→D1 Mice
Detected by In Situ Hybridization
Sections of 14.5 day postcoitum wild-type
(WT) and cyclin E→D1 (KI) embryos were hy-
bridized with indicated probes. Specimens
were photographed by double exposure us-
ing dark-field illumination with a red filter and
Hoechst epifluorescence optics. The blue
color represents the Hoechst staining of cell
nuclei, and the red represents the hybridiza-
tion signal. Note that the red signal within
the retinal pigment layer represents a false
positive signal that stains with all probes due
to the presence of pigmented granules in
these cells. R, neural part of the retina. Magni-
fication approximately 1163.
expressed in place of cyclin D1, can substitute for cyclin mammary lobuloalveolar development that was interme-
diate between that seen in wild-type and in cyclin D12/2D1 function in this tissue.
females. Moreover, the remaining 30% of cyclin E→D1
females resembled cyclin D12/2 females in their mam-
Effect of Knockin Cyclin E on the Mammary mary development (not shown). We reasoned that the
Phenotype of Cyclin D12/2 Mice observed variability was likely caused by factors that
As reported previously, cyclin D1±deficient mice de- were extrinsic to the mammary epithelium and varied
velop normal mammary glands during sexual matura- from animal to animal due to the mixed genetic back-
tion. However, these mammary glands fail to undergo ground of mice used for analyses.
normal lobuloalveolar development during pregnancy. In order to eliminate this variability and to firmly estab-
As a consequence, cyclin D1±deficient females display lish whether cyclin E could replace cyclin D1 in driving
grossly underdeveloped mammary epithelial trees at the pregnancy-induced mammary epithelial proliferation,
end of pregnancy and are unable to nurse their pups we turned to a mammary epithelial transplantation tech-
(Fantl et al., 1995; Sicinski et al., 1995). nique (Robinson et al., 1998). In this procedure, a frag-
In our analyses of homozygous cyclin E→D1 females, ment of mammary epithelium derived from a mutant
we first confirmed that the development of mammary mouse is transplanted into a cleared mammary fat pad of
glands during sexual maturation proceeds normally in a wild-type recipient female that is devoid of an epithelial
these mice (not shown). We then turned our attention tree. It is now well established that the engrafted epithe-
to lobuloalveolar development during pregnancy, a step lium behaves essentially like the mammary epithelium
that is profoundly compromised in cyclin D12/2 females. of host animals and undergoes the same morphological
Analyses of cyclin E→D1 females at day 1 postpartum changes when host animals undergo sexual maturation
revealed that approximately 35% of mutant females un- or pregnancy (Robinson et al., 1998). Thus, this proce-
derwent a lobuloalveolar mammary development that dure allowed us to examine cell-autonomous properties
was indistinguishable from that of wild-type females (not of cyclin E→D1 mammary epithelium and made it possi-
shown). These cyclin E→D1 females were able to nurse ble to compare side by side the development of mam-
their pups normally. This behavior of cyclin E→D1 mice mary epithelia derived from different mutants within the
was in stark contrast with cyclin D12/2 females, which same recipient mouse.
never breast-fed their pups. We noted, however, that We dissected mammary epithelia from wild-type,
cyclin D12/2, and cyclin E→D1 females and transplantedapproximately 30% of cyclin E→D1 females underwent
Cell
772
Figure 5. Rescue of the Retinal Abnormality in Cyclin E→D1 Mice
(A) Histologic sections of retinas derived from a 16-day-old wild-type (WT), cyclin D12/2 (KO), and cyclin E→D1 (KI) mouse. The paraffin
sections were stained with hematoxylin and eosin. G, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer; PE, retinal pigmented
epithelium. Magnification approximately 1003. Below, representative electroretinographic (ERG) potentials recorded from a 2- to 3-month-
old wild-type, cyclin D12/2, and cyclin E→D1 mouse in response to a 0.1 Hz flash of white light delivered at time 0.
(B) Total thickness, the width of all layers of the neuroretina, measured from the boundary between pigment epithelium and neuroretina to
the ganglion cell layer (inner limiting membrane); GCL, the number of cell nuclei in the ganglion cell layer per 175 mm of retinal length; INL
and ONL, the number of nuclear layers in the inner nuclear (INL) and outer nuclear (ONL) layers. The values for retinas of wild-type (dotted
bars), cyclin D12/2 (black bars), and cyclin E→D1 mice (white bars) are represented in arbitrary units. The actual values for wild-type, cyclin
D12/2, and cyclin E→D1 retinas were (respectively): total thickness, 206 6 23 mm (6SD), 71 6 13 mm, 152 6 18 mm; GCL, 22.7 6 4.1, 7.7 6
2.7, 18.3 6 4.4; INL, 5.3 6 0.9, 2.2 6 0.4, 4.0 6 0.6; ONL, 10.9 6 0.6, 2.7 6 0.8, 5.8 6 0.9. The number of mice analyzed was n 5 16, 14, and
23, respectively; all animals were 16 days to 4.5 months old. One retinal section (such as those shown in [A]) per mouse was analyzed.
Measurements were taken approximately at the midpoint between ora serrata and the optic disc.
them into cleared fat pads of wild-type hosts. When the as donors for mammary epithelial transplantations (not
shown). Based on these experiments, we concludedrecipients became pregnant, the transplanted wild-type
epithelium underwent a massive lobuloalveolar develop- that knockin human cyclin E can essentially fully replace
cyclin D1 in driving mammary epithelial proliferation.ment (Figure 6A) that was indistinguishable from the
development of endogenous, unmanipulated mammary
glands of the recipient animals (not shown). As demon- Absence of Additional Phenotypes in Cyclin E→D1
Heterozygous and Homozygous Micestrated previously (C. Brisken and R. A. W., unpub-
lished), the transplanted cyclin D12/2 epithelium failed to In addition to the studies described above, we subjected
tissues derived from cyclin E→D1 mice as well as fromundergo lobuloalveolar proliferation when the recipients
became pregnant, confirming the intrinsic inability of cyclin E→D1/1 heterozygotes to detailed histopatho-
logical analyses. These analyses revealed normal mor-mutant epithelium to respond to pregnancy-associated
morphogenetic signals (Figure 6A). In striking contrast, phogenesis in all tissues studied. Thus, apart from cor-
recting the known phenotypes of cyclin D1 deficiency,the transplanted cyclin E→D1 epithelium underwent full
lobuloalveolar development that closely resembled the the ectopic expression of cyclin E does not cause any
detectable developmental abnormalities.morphogenesis seen in wild-type epithelium (Figure 6A).
The above conclusions were reached using trans-
plantations of mammary epithelium derived from ani- Molecular Mechanism of the Rescue of Cyclin
D12/2 Phenotypesmals of mixed genetic background. The same results
were obtained when the cyclin D12/2 and cyclin E→D1 It was possible that the observed rescue of the pheno-
typic manifestations of cyclin D1 deficiency by humanalleles were bred into the pure 129Sv genetic back-
ground; these genetically pure mice were then used cyclin E might be due to the ability of this cyclin to elicit
Replacement of Cyclin D1 by Cyclin E
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Figure 6. Rescue of Mammary Epithelial De-
fect in Cyclin E→D1 Mice
(A) The appearance of wild-type (WT), cyclin
D12/2 (KO), and cyclin E→D1 (KI) mammary
epithelial tree prior to the pregnancy (virgin)
and 1 day after the delivery of pups (postpar-
tum). The mammary epithelium was trans-
planted into wild-type recipients. The whole
mounts of inguinal mammary glands were
prepared, and the epithelial component was
stained with carmine red. Magnification ap-
proximately 23.
(B) Expression of mouse cyclin D1 mRNA or
human cyclin E mRNA in the mammary
glands of pregnant (day 14.5 of gestation)
wild-type (WT) or cyclin E→D1 (KI) females,
detected by in situ hybridization as described
in the legend to Figure 4. Magnification ap-
proximately 1163.
an upregulation of endogenous mouse cyclins D2 or D3, same pattern of expression was observed in cyclin
E→D1 females, with the exception that cyclin D1 wasresulting in functional replacement of cyclin D1. To test
this notion, we determined the expression pattern of replaced by human cyclin E (Figure 6B and not shown).
Again we concluded that the observed rescue in cyclinD-cyclins in the developing retinas and mammary glands
of cyclin E→D1 mice and compared these with the pat- E→D1 mice seems to be caused directly by human
cyclin E expression rather than indirectly through theterns seen in wild-type animals, using in situ hybridiza-
tion and Western blotting. ability of cyclin E to cause upregulation of cyclins D2
or D3.The analyses of developing retinas revealed that in
wild-type mice this tissue expressed very high levels of We next asked whether the knockin human cyclin E
replaced cyclin D1 function by associating with the nor-cyclin D1, no cyclin D2, and very low levels of cyclin D3
mRNA (Figure 4) and protein (not shown). Analyses of mal kinase partner of cyclin E, CDK2, or alternatively by
binding to cyclin D±specific partners CDK4 or CDK6. Toretinas derived from cyclin E→D1 mice showed that
these retinas expressed very high levels of knockin hu- address these alternatives, we microdissected devel-
oping retinas or removed mammary glands from preg-man cyclin E, no cyclins D1 or D2, and only very low
levels of cyclin D3 mRNA (Figure 4) and protein (not nant wild-type or cyclin E→D1 mice, prepared protein
lysates, immunoprecipitated mouse cyclin D1 or humanshown). Accordingly, the observed rescue of retinal mor-
phogenesis and function in the cyclin E→D1 mice seems cyclin E with appropriate antibodies, and probed immu-
noblots with antibodies directed against CDK2, CDK4,to be caused directly by human cyclin E expression
rather than indirectly through the ability of cyclin E to or CDK6.
As expected, immunoprecipitation of cyclin D1 fromcause upregulation of cyclins D2 or D3.
Similar analyses of mammary glands derived from wild-type tissues resulted in coprecipitation of substan-
tial amounts of CDK4 and low levels of CDK6. In addition,pregnant wild-type and cyclin E→D1 females demon-
strated that the mammary glands of wild-type mice ex- cyclin D1 brought down small amounts of CDK2 (Figure
7A and not shown); indeed, cyclin D1 is known to formpressed cyclin D1, no cyclin D2, and low levels of cyclin
D3 mRNA and protein (Figure 6B and not shown). The catalytically inactive complexes with CDK2.
Cell
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Immunoprecipitation of human cyclin E from cyclin
E→D1 extracts brought down CDK2, but neither CDK4
nor CDK6 was present in these precipitates (Figure 7A).
Thus, in the retinas and mammary glands of cyclin E→D1
mice, human cyclin E associates exclusively with its
normal partner, CDK2, and not with the cyclin D±specific
partners CDK4 and CDK6.
We then turned our attention to two known properties
of cyclin D1±CDK4/6 complexes, namely the ability to
sequester the CDK inhibitor p27Kip1 and the ability to
phosphorylate the retinoblastoma protein pRB. We
asked whether ectopically expressed cyclin E±CDK2
complexes could drive cell cycle progression of cyclin
E→D1 cells by replacing these two functions of cyclin
D1±CDK4/6 complexes or, alternatively, by bypassing
them.
To address these possibilities, we first examined the
association of cyclin D1 and human cyclin E with p27Kip1
in the developing retinas. To this end, we prepared pro-
tein lysates from microdissected wild-type and cyclin
E→D1 retinas, immunoprecipitated cyclin D1 or human
cyclin E with appropriate antibodies, and probed immu-
noblots with an antibody directed against p27Kip1.
As expected, immunoprecipitation of cyclin D1 from
wild-type retinas resulted in coprecipitation of substan-
tial amounts of p27Kip1. In contrast, immunoprecipitation
of human cyclin E from cyclin E→D1 retinas failed to
bring down significant amounts of p27Kip1 (Figure 7B).
Hence, at this level of analysis, it appeared that the
human cyclin E±containing complexes did not function
through an ability to sequester cellular p27Kip1.
Despite this result, it was nevertheless possible that
knockin human cyclin E associated with p27Kip1 at a par-
ticular stage of cell cycle progression. To test this possi-
bility, we synchronized wild-type and cyclin E→D1 MEFs
by serum deprivation and then stimulated them to enter
the cell cycle by addition of serum. Cells were harvested
at different points of cell cycle progression, protein ly-
sates were prepared, and the association between
cyclin D1 and p27Kip1 or human cyclin E and p27Kip1 was
monitored as described above. Consistent with the pre-
Figure 7. Molecular Analyses of Cyclin E→D1 Retinas and Mam- vious result, we detected only very low levels of p27Kip1
mary Glands associated with human cyclin E (not shown).
(A) Association of ectopically expressed human cyclin E with CDKs. We also entertained the alternative possibility that
Protein extracts prepared from developing wild-type (WT) or cyclin
ectopically expressed human cyclin E, instead of bind-E→D1 (KI) retinas were immunoprecipitated with antibodies against
ing and sequestering p27Kip1, might affect total levels ofhuman cyclin E (IP-hE) or mouse cyclin D1 (IP-mD1); immunoblots
this protein by causing its premature degradation. Towere probed with antibodies against CDK2 and CDK4.
(B) Association of ectopically expressed human cyclin E with p27Kip1. address this possibility, we used immunoblotting to de-
Protein extracts prepared from developing wild-type (WT) or cyclin termine the levels of p27Kip1 as well as that of another
E→D1 (KI) retinas were immunoprecipitated (IP) with antibodies CDK inhibitor, p21Cip1, during cell cycle progression of
against mouse cyclin D1 (mD1) or human cyclin E (hE); immunoblots wild-type and cyclin E→D1 MEFs. These analyses re-
were probed with antibody against p27Kip1. For comparison, immu-
vealed precisely the same pattern of p27Kip1 and p21Cip1noblots of retinal protein lysates were probed with the same
expression in wild-type and mutant cells during cell cy-antibody.
cle progression (not shown). Hence, human cyclin E did(C) Retinoblastoma protein (pRB) phosphorylation in developing
wild-type (WT), cyclin E→D1 (KI), and cyclin D12/2 (KO) retinas and not perturb the levels of these critical CDK inhibitors.
in mammary glands of pregnant (day 16.5 of gestation) females. We then asked whether ectopically expressed knockin
Immunoblots of protein lysates were probed with an anti-pRB anti- cyclin E replaced cyclin D1 in driving the phosphory-
body. Below, the ratio of hyperphosphorylated to hypophosphory-
lation of the retinoblastoma protein. To address this is-lated pRB in the retinal lysates, as determined by densitometric
sue, we prepared protein extracts from microdissectedscanning of relevant bands in three different immunoblots. Error
bars represent SE.
(D) Response of wild-type (WT), cyclin E→D1 (KI), and cyclin D12/2
(KO) mammary glands to estrogen. Ovariectomized mice received a mice; 6 h, ovariectomized mice 6 hr after estrogen injection. The
single injection of estradiol. The induction of progesterone receptor sizes of ribosomal subunits are shown on the right. GAPDH hybrid-
mRNA was determined by Northern blotting. 0 h, ovariectomized ization was used to control for equal loading of samples.
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cyclin E→D1, cyclin D12/2, and wild-type retinas and present work, we asked whether cyclin E can replace
cyclin D1 and rescue the phenotypic manifestations offrom mammary glands of pregnant animals. Immu-
cyclin D1 deficiency. We reasoned that these analysesnoblots of these extracts were probed with an anti-pRB
would represent a highly sensitive and stringent mea-antibody that permits one to distinguish between hypo-
sure of functional interactions between these two cyclins.phosphorylated pRB (fast-migrating form) and hyper-
To address this issue, we have replaced the codingphosphorylated pRB (slow-migrating form). We then de-
sequence of mouse cyclin D1 with that of human cyclin Etermined the ratio between hyperphosphorylated and
in the mouse germline. As a consequence, we generatedhypophosphorylated pRB.
cyclin E→D1 knockin mice that lack cyclin D1 (like cyclinAs shown in Figure 7C, the developing wild-type reti-
D12/2 mice) and express human cyclin E in its place. Innas expressed a high ratio of phosphorylated pRB
the cells of these knockin mice, the expression of human(which we arbitrarily set at 100%). In contrast, in the
cyclin E is driven by the cyclin D1 promoter, and conse-retinas of cyclin D12/2 mice, the proportion of hyper-
quently, human cyclin E is predicted to be targeted tophosphorylated pRB was reduced to approximately
tissues normally expressing cyclin D1. Indeed, our de-23%. Cyclin E→D1 retinas displayed approximately 35%
tailed analyses of cyclin E→D1 mice fully validated thisof normal pRB phosphorylation levelsÐa value clearly
notion. Importantly, the levels of human cyclin E proteinhigher but still close to that seen in cyclin D12/2 tissues
(not shown) and the schedule of its cell cycle±specific(Figure 7C). A similar pattern of pRB phosphorylation
expression (Figure 2) faithfully mimic that of cyclin D1was seen in mammary glands of pregnant animals (Fig-
in wild-type tissues. This outcome could not have beenure 7C and not shown). We concluded that ectopically
predicted, since the posttranslational fates of the cyclinexpressed cyclin E does not restore full pRB phosphory-
D1 and cyclin E proteins are controlled by quite differentlation and that it must therefore function to drive cell
mechanisms.proliferation by bypassing the requirement for full pRB
Our analyses of cyclin E→D1 mice revealed unexpect-phosphorylation in these tissues. This finding is consis-
edly that the expression of cyclin E in place of cyclintent with the observations that overexpression of cyclin
D1 can rescue all known phenotypic manifestations ofE in in vitro±cultured cells can overcome cell cycle arrest
cyclin D1 deficiency. Thus, while cyclin D12/2 mice dis-induced by a phosphorylation-deficient pRB mutant
play a neurologic abnormality, hypoplastic retinas and(Alevizopoulos et al., 1997; Leng et al., 1997; Lukas et
hypoplastic mammary glands, ectopic expression ofal., 1997).
cyclin E restores nearly normal development to these
tissues.Cyclins D1 and E and the Estrogen Receptor
The second very unexpected outcome of our analysesIn addition to its role in cell cycle progression, cyclin
is the observation that ectopic expression of cyclin E inD1 has been shown to play a CDK-independent role in
cyclin E→D1 mice did not lead to any novel, additionalmammary epithelium by interacting with the estrogen
phenotypes. In short, we conclude that the functions ofreceptor (ER) and serving as an ER coactivator in cul-
cyclin D1 and cyclin E are fully exchangeable.tured cells (Neuman et al., 1997; Zwijsen et al., 1997).
This functional replacement is hard to reconcile withFor this reason, we decided to evaluate the respon-
current models of cell cycle progression. The cells of allsiveness of cyclin D12/2 and cyclin E→D1 mammary
higher organisms studied, from Caenorhabditis elegansepithelium to estrogen by gauging the induction of the
and Drosophila melanogaster to man, express distinctmajor mammary epithelial ER-responsive gene, the pro-
D-type and E-type cyclins during G1 phase progression.gesterone receptor (PR) (Savouret et al., 1991). To this
The schedule of activity of these two classes of cyclins
end, we injected ovariectomized wild-type, cyclin D12/2,
during cell cycle progression is quite different. Thus,
and cyclin E→D1 mice with a single dose of estrogen
D-type cyclins operate in mid-G1 phase, while cyclin E
and determined the levels of PR mRNA 6 hr later using and presumably mammalian E2 (Lauper et al., 1998;
Northern blotting. Zariwala et al., 1998; Gudas et al., 1999) act at the end
As expected, administration of estrogen to wild-type of G1. This suggests a model in which these two types
mice led to a very strong, over 10-fold induction of the of cyclins act sequentially during the normal cell cycle to
PR mRNA (Figure 7D). Importantly, cyclin D12/2 and enable cells to progress through G1 and enter S phase.
cyclin E→D1 mammary glands responded to estrogen What then is the molecular basis of the observed res-
in precisely the same fashion (Figure 7D). Thus, the in- cue of cyclin D1 functions by cyclin E? We have consid-
duction of the PR gene, the major ER-responsive target ered two possibilities. (1) Knockin cyclin E-CDK2 com-
in the mammary epithelium, proceeds normally in the plexes replace the functions normally executed by cyclin
absence of cyclin D1, and this response is not altered D1±CDK4/6 complexes. (2) The cyclin E→D1 allele re-
by ectopic expression of cyclin E. sults in ectopic expression of the major downstream
target of cyclin D1, thereby obviating the need for cyclin
Discussion D1 in cell cycle progression, revealing that cyclin E is
the major rate-limiting target for cyclin D1.
The work described here derived from earlier observa- The evidence presented in this paper strongly favors
tions that cyclin D12/2 mice exhibit developmental de- the latter scenario. Thus, cyclin D1 is believed to play
fects in at least three distinct tissues (Fantl et al., 1995; at least two functions in cell cycle progression. First, it
Sicinski et al., 1995). In each of these three tissues, we drives the phosphorylation of the pRB. Indeed, cells
presume that cyclin D1 is rate limiting for proliferation that have lost pRB no longer require cyclin D1 for their
and that the other D-type cyclins are not present in growth, indicating that pRB is the major downstream
target of cyclin D1 (Sherr and Roberts, 1995). Second,amounts adequate to make up for its absence. In the
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cyclin D1 induction causes the redistribution of a cellular was evolved in order to enable metazoan cells to con-
kinase inhibitor, p27Kip1, from the cyclin E±CDK2 pool nect extracellular signals with cyclin E activation, thereby
to the cyclin D±CDK4/6 pool, thereby liberating cyclin controlling the entrance into S phase. Since this cyclin
E±CDK2 complexes from inhibition and resulting in their D±pRB pathway is subverted in essentially all human
activation (Sherr and Roberts, 1995). cancers, the elucidation of its role in driving normal cell
We have examined both functions of cyclin D1 in the proliferation is essential to understanding the molecular
tissues of cyclin E→D1 mice and found that neither of basis of malignant cell growth.
these cyclin D1±dependent functions is replaced by the
ectopically expressed human cyclin E. Consequently, Experimental Procedures
we conclude that the ectopic cyclin E→D1 allele rescues
Generation of Cyclin E→D1 Micethe proliferation of cyclin D1±dependent tissues by by-
The cyclin D1 knockout vector (Sicinski et al., 1995) was modifiedpassing the functions of cyclin D1 rather than by replac-
to obtain cyclin E→D1 knockin vector as follows: (1) the 600 bping them. This indicates, in turn, that cyclin E activity is
XbaI±XbaI fragment of the cyclin D1 gene was deleted; (2) the 1666the major downstream rate-limiting target for cyclin D1
bp BamHI±HindIII fragment of human cyclin E cDNA (a kind gift
and that ectopic cyclin E expression, as achieved from Dr. M. Pagano), starting at nucleotide position 84 within the
through the cyclin E→D1 allele, bypasses the need for 59 untranslated sequence, containing the entire coding sequence
cyclin D1 in cell cycle progression. and 298 bp of 39 untranslated sequence, and ending at nucleotide
1750 (Ohtsubo et al., 1995) was cloned into the EagI site at nucleo-Currently available information on the mammalian cell
tide position 180 within the 59 untranslated sequence of the cyclincycle enables one to postulate how this functional re-
D1 gene (Figure 1).placement might occur. pRB is the major target for cyclin
The procedure to obtain cyclin E→D1 heterozygous ES cells and
D±CDK4/6 complexes (Sherr and Roberts, 1995). When mice was as described for cyclin D1±deficient animals; the same
hypophosphorylated, pRB binds and sequesters several probes were used for Southern blot analyses (Sicinski et al., 1995).
proteins, most notably transcription factors of the E2F Three hundred and eight ES cell clones were analyzed, and six
underwent homologous recombination. Germline transmission wasfamily. The phosphorylation of pRB leads to the release
obtained with two clones, and mice deriving from both clones wereof these captive proteins, which then proceed to trans-
used for subsequent studies. Genotyping of mice was performedactivate target genes. Alternatively, the dissociation of
as described (Sicinski et al., 1995) with the exception that the primerpRB from E2Fs removes a transcription-repressing fac-
N was substituted with the primer E (59-CAC AGA CTG CAT TAT
tor from E2Fs bound to control elements of certain pro- TGT CCC AAG G-39). The sizes of amplification products are 224
moters (Weinberg, 1995). One of the genes regulated bp for a wild-type allele and 461 bp for a mutated allele.
by the E2Fs is cyclin E (Ohtani et al., 1995; Botz et al.,
1996; Geng et al., 1996), leading to the hypothesis that Cell Cycle Analyses
cyclin D1 serves to control the activity of cyclin E via Embryonic fibroblasts were isolated from day 13.5 postcoitum ho-
mozygous cyclin E→D1 or wild-type embryos as described (SicinskipRB and E2Fs. An elaboration of this model predicts
et al., 1995). Cells were starved in serum-free Dulbecco's modifiedthat cyclin D1±CDK4/6 complexes bring about the initial,
Eagle's medium for 42±87 hr before being restimulated with 15%ªpreparatoryº pRB phosphorylation, leading to the in-
fetal bovine serum for indicated times. [3H]thymidine labeling was
duction of small amounts of cyclin E (Lundberg and for 60 min before lysis and counting.
Weinberg, 1998). The end consequence of these steps
is the activation of cyclin E, whose ectopic expression, Western Blot, Immunoprecipitation, and Kinase Assays
as described here, appears to obviate the function of Retinas were microdissected from 1-day-old neonates. Mammary
cyclin D1. glands were collected from pregnant mice at days 16.5 to 18.5 of
gestation or at 1 day after delivery. Fifty to two hundred microgramsApart from its role as a partner of CDK4 and CDK6
of proteins were separated using 10% SDS-PAGE (or 6% for pRBkinases, cyclin D1 has been reported to play a unique
analyses) and transferred to NitroBind membrane (MSI). The immu-role as an ER coactivator (Neuman et al., 1997; Zwijsen
noblots were probed with the following primary antibodies (all fromet al., 1997). This might suggest that the observed defect
Santa Cruz, except where indicated): anti-cyclin D1 (72-13G); anti-
in the mammary development of cyclin D12/2 mice de- cyclin D2 (34B1-3); anti-cyclin D3 (C-16); anti-mouse cyclin E (M-20);
rived from inadequate activation of the ER in this tissue. anti-human cyclin E (HE-12); anti-CDK2 (M2); anti-CDK4 (C22); anti-
The evidence presented in this paper argues against p27 (C-19); and anti-pRB (245, Pharmingen). As a secondary anti-
body, peroxidase-conjugated IgG (Jackson ImmunoResearch) wasthis explanation. First, we have shown that cyclin E,
used, followed by enhanced chemiluminescence (ECL) detectionwhich was reported not to bind the ER and not to serve
(Amersham).as ER coactivator (Zwijsen et al., 1997), can replace
For immunoprecipitations, 100 mg of protein lysates was incu-cyclin D1 in driving normal mammary epithelial develop-
bated with anti-mouse cyclin D1 antibody (72-13G) or with anti-
ment. Second, we have shown that the induction of a human cyclin E antibody (HE-111, Santa Cruz) conjugated to aga-
major mammary epithelial ER-responsive gene, the PR rose beads. For kinase assays, 100 mg of protein lysates was
(Savouret et al., 1991), proceeds normally in cyclin D1± incubated with anti-human cyclin E antibody (HE-111) or with anti-
mouse E antibody (M-20) conjugated to agarose beads. Immunopre-deficient mice. These findings have led us to the conclu-
cipitates were subjected to kinase reactions in 15 ml of 20 mM Trission that the crucial role for cyclin D1 in mammary devel-
(pH 7.5), 5 mM MgCl2, 2.5 mM MnCl2, 1 mM dithiothreitol, 0.013 mMopment reflects the activity of cyclin D1 toward other
ATP, 2 mCi [g-32P]ATP, and 2.5 mg histone H1 for 30 min at 308C.targets, such as pRB.
The studies described in this paper strongly suggest
In Situ Hybridizationthat cyclin E is the major rate-limiting target for cyclin
For human cyclin E probe, a 501 bp fragment of human cyclin E
D1 in mammalian cells. This, together with the well- cDNA, nucleotides 1038±1539 (Ohtsubo et al., 1995) was cloned
established fact that the D-type cyclins are controlled into pBluescript. Sense and antisense probes were generated using
by extracellular signals, while E cyclins are controlled T3 or T7 polymerase, respectively. Mouse cyclin D probes were as
described (Sicinski et al., 1995, 1996).internally, might suggest that the cyclin D±pRB pathway
Replacement of Cyclin D1 by Cyclin E
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Mammary Epithelial Transplantations and Look, A.T. (1992). Genomic organization, chromosomal localiza-
tion, and independent expression of human cyclin D genes. Geno-These were done as described (Robinson et al., 1998). As donors,
we used (1) mixed genetic background (129Sv/C57BL/6): six cyclin mics 13, 565±574.
E→D1, six cyclin D12/2, and eight wild-type (WT) females, age 1.5±10 Lauper, N., Beck, A.R., Cariou, S., Richman, L., Hofmann, K., Reith,
months; (2) pure 129Sv background: four cyclin E→D1, four cyclin W., Slingerland, J.M., and Amati, B. (1998). Cyclin E2: a novel CDK2
D12/2, and six WT females, age 12±51 days. As recipients, we used partner in the late G1 and S phases of the mammalian cell cycle.
Rag12/2 females, B6,129-Rag1tm1Mom or C57BL/6J-Rag1tm1Mom, pur- Oncogene 17, 2637±2643.
chased from Jackson Laboratories. Each recipient mouse received Leng, X., Connell-Crowley, L., Goodrich, D., and Harper, J.W. (1997).
two transplants (WT and cyclin E→D1, WT and cyclin D12/2, or cyclin S-phase entry upon ectopic expression of G1 cyclin-dependent ki-
E→D1 and cyclin D12/2), one into each inguinal mammary gland. nases in the absence of retinoblastoma protein phosphorylation.
Two months after the transplantations, mice were mated; mammary Curr. Biol. 7, 709±712.
glands were collected at days 1±2 postpartum and whole mounts
Lukas, J., Herzinger, T., Hansen, K., Moroni, M.C., Resnitzky, D.,prepared.
Helin, K., Reed, S.I., and Bartek, J. (1997). Cyclin E-induced S phase
without activation of the pRb/E2F pathway. Genes Dev. 11, 1479±
Progesterone Receptor Analysis 1492.
Virgin females (2 to 4.5 months old) were ovariectomized. Eight Lundberg, A.S., and Weinberg, R.A. (1998). Functional inactivation
days later, mice received subcutaneous injection of 17b-estradiol of the retinoblastoma protein requires sequential modification by at
(Sigma), 0.05 mg per gram of body weight, and were sacrificed after least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18, 753±761.
6 hr. Total RNA was isolated from pooled mammary glands derived
Neuman, E., Ladha, M.H., Lin, N., Upton, T.M., Miller, S.J., Di Renzo,from two to three mice per experimental group as described (Geng
J., Pestell, R.G., Hinds, P.W., Dowdy, S.F., Brown, M., and Ewen,and Weinberg, 1993), and poly A1 mRNA was purified using an
M.E. (1997). Cyclin D1 stimulation of estrogen receptor transcrip-Oligotex mRNA kit (Qiagen). Eight micrograms of poly A1 RNA
tional activity independent of cdk4. Mol. Cell. Biol. 17, 5338±5347.was resolved using 1% MOPS-formaldehyde gels, transferred to
Ohtani, K., De Gregori, J., and Nevins, J.R. (1995). Regulation of theMagnaGraph membrane (MSI), and probed with radiolabeled full-
cyclin E gene by transcription factor E2F1. Proc. Natl. Acad. Sci.length murine PR cDNA (a kind gift from Dr. G. Shyamala) or glyceral-
USA 92, 12146±12150.dehyde dehydrogenase (GAPDH) cDNA as described (Geng and
Weinberg, 1993). Ohtsubo, M., Theodoras, A.M., Schumacher, J., Roberts, J.M., and
Pagano, M. (1995). Human cyclin E, a nuclear protein essential for
the G1-to-S phase transition. Mol. Cell. Biol. 15, 2612±2624.Other Procedures
Robinson, G.W., Johnson, P.F., Hennighausen, L., and Sterneck,Histology, mammary gland whole mounts, and electroretinographic
E. (1998). The C/EBPb transcription factor regulates epithelial celltesting was performed as described (Sicinski et al., 1995).
proliferation and differentiation in the mammary gland. Genes Dev.
12, 1907±1916.
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